Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- Check3 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor update to the page or its underlying components. This reflects a version increment rather than a substantive change to content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page; this represents a small internal update to the page rendering or documentation rather than a change to study information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a deployment/patch update. This change is a backend/metadata update and does not modify the study details or the information presented to users.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of Revision: v3.6.0, indicating a minor update to the page. This change does not alter the study details shown.SummaryDifference0.0%

- Check61 days agoChange DetectedRecruitment is closed for this study, and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, while the Intervention/Treatment header formatting and the revision label were updated to v3.6.0.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4. This reflects a behind-the-scenes update to the page's build or rendering.SummaryDifference0.0%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.